Avacta to launch Affimer-based ELISA test for SARS-CoV-2 virus detection


Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19.

Source: https://www.news-medical.net/news/20200908/Avacta-to-launch-Affimer-based-ELISA-test-for-SARS-CoV-2-virus-detection.aspx

Catherine Sally McCallister
Catherine Sally McCallisterhttp://www.thedispensary.com.sg
Catherine Sally McCallister is a 25-year-old semi-professional sports person who enjoys going to the movies, binge-watching boxed sets and helping old ladies across the road. She is exciting and giving, but can also be very calculative and a bit stingy in praising people.

Stay in Touch

To follow the best weight loss journeys, success stories and inspirational interviews with the industry's top coaches and specialists. Start changing your life today!

Related Articles